摘要心搏骤停（CA）是全球性的高发性急危重症，提高CA患者的生存率和改善严重的不良预后是心肺复苏（CPR）技术发展的方向。β受体阻滞剂能够选择性地阻断递质或受体激动药，由于其明确的药理学特点而广泛应用于心血管疾病的治疗。通过检索国内外医学数据库文献，围绕β受体阻滞剂在临床中的应用、CA后的动物实验和临床研究结果，总结近年来β受体阻滞剂在CPR中的研究进展。

abstractsCardiac arrest (CA) is an acute critical illness with the high occurrence in the world. The directions of cardiopulmonary resuscitation (CPR) development are to improve CA patients' survival rate and to decrease the poor prognosis. β-blockers can selectively block the neurotransmitter or receptor agonists. They offer beneficial pharmacological properties and have been widely used in the treatment of cardiovascular diseases. Based on the search result of the domestic and foreign medical databases, the usage of β-blockers including clinical research, animal experiments and clinical work of CPR patients was summarized. Finally, the CPR research progress of β-blockers in recent years was reviewed in the article.